Vancomycin-resistant enterococci in intensive care units: High frequency of stool carriage during a non-outbreak period

Archives of Internal Medicine

Volumn 159, Issue 13, 1999, Pages 1467-1472

  Ostrowsky, Belinda E ^a,c   Venkataraman, Lata ^a   D'Agata, Erika M C ^b   Gold, Howard S ^a   DeGirolami, Paola C ^a   Samore, Matthew H ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; ENTEROCOCCUS; FEMALE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR;

AGED; ANTI-BACTERIAL AGENTS; BOSTON; CELL CULTURE TECHNIQUES; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; FEMALE; HUMANS; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; VANCOMYCIN;

EID: 0033549632     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.13.1467     Document Type: Article

References (29)

1. Centers for Disease Control. Nosocomial enterococci resistant to vancomycin -United States, 1989-1993. MMWR Morbid Mortal Wkly Rep. 1993;42:597-599.
2. Moellering RC Jr. Emergence of enterococcus as a significant pathogen. Clin Infect Dis. 1992;14:1173-1178.
3. Quale J, Landman D, Saurina G, Atwood E, DiTorre V, Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak vancomycin-resistant enterococci. Clin Infect Dis. 1996;23:1020-1025.
4. Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol. 1995;16:105-113.
5. Frieden TR, Munsiff SS, Low DE, et al. Emergence of vancomycin-resistant enlerococci in New York City. Lancet. 1993;342:76-79.
6. Chow JW, Fine MJ, Shlaes DM, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med. 1991; 115:585-590.
7. Morris JG Jr, Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med. 1995;123:250-259.
8. Karanfil LV, Murphy M, Josephson A, et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol. 1992;13:195-200.
9. Montecalvo MA, Shay DK, Patel P, et al. Bloodstream infections with vancomycin-resistant enterococci. Arch Intern Med. 1996;156:1458-1462.
10. Luber AD. Relative importance of oral versus intravenous vancomycin exposure in the development of vancomycin-resistant enterococci. J Infect Dis. 1996; 173: 1292-1293.
11. Shay DK, Maloney SA, Montecalvo M, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis. 1995; 172:993-1000.
12. Boyle JF, Soumakis SA, Rendo A, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol. 1993;31:1280-1285.
13. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: Risk factors for infection. Clin Infect Dis. 1995;20:1126-1133.
14. Quale J, Landman D, Atwood E, et al. Experience with a hospital-wide outbreak of vancomycin-resistant enterococci. Am J Infect Control. 1996;24:372-379.
15. Livornese LL, Dias S, Samel C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med. 1992;117:112-116.
16. Bonten M, Hayden M, Nathan C, et al. Epidemiology of colonization of patients and environment with vancomycin-resistant enterococci. Lancet. 1996;348: 1615-1619.
17. Slaughter S, Hayden M, Nathan C, et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med. 1996125: 448-456.
18. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991; 100:1619-1636.
19. Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
20. D'Agata E, Venkataraman L, DeGirolami P, et al. Colonization with broad spectrum cephalosporin-resistant gram negative bacilli in intensive care units during a non-outbreak period: prevalence, risk factors, and rate of infection. Crit Care Med. In press.
21. Facklam RR, Sahm DF. Enterococcus. In: Murray PR, ed. Manual of Clinical Microbiology. 6th ed. Washington, DC: American Society for Microbiology (ASM) Press; 1995:308-314.
22. National Committee for Clinical Laboratory Standards. Methods for dilution: Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 4th ed. Villanova, Pa: National Committee for Clinical Laboratory Standards; 1997. NCCLS document M7-A4.
23. Maslow J, Slutsky AM, Arbeit RD. The application of pulsed-field gel electrophoresis to molecular epidemiology. In: Persing DH, Smith TF, Tenover FC, White J, eds. Diagnostic Molecular Microbiology: Principals and Applications. Washington, DC: American Society for Microbiology; 1993:563-572.
24. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DMA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-2239.
25. Handwerger S, Raucher B, Altarac D, Monka J, Marchione S, Singh KV. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis. 1993;16:750-755.
26. Boyce JM, Opal SM, et al. Outbreak of multi-drug resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol. 1994; 32:1148-1153.
27. Pallares R, Pujol M, Pena C, et al. Cephalosporins as risk factor for nosocomial Enterococcus faecalis bacteremia: a matched case-control study. Arch Intern Med. 1993;153:1581-1586.
28. Samore M, Gold H, Eichelberger K, et al. Increased incidence of vancomycin-resistant enterococci (VRE) associated with diverse strains and parenteral antibiotic exposure. In: Abstracts of the 95th General Meeting of the American Society for Microbiology; May 21-25, 1995; Washington, DC.
29. Bonten MJ, Nathan C, Weinstein RA. Recovery of nosocomial fecal flora from frozen stool specimens and rectal swabs: comparison of preservatives for epidemiological studies. Diagn Microbiol Infect Dis. 1997;27:103-106.